Skip to content

H.R. 7384 · 118th Congress (2023–2025)

Creating Hope Reauthorization Act of 2024

This bill extends until FY2029 a Food and Drug Administration program that awards priority review vouchers to manufacturers of drugs that treat rare pediatric diseases. (A priority review voucher entitles the voucher holder to priority review of a single human drug application.)

Show official title

To amend the Federal Food, Drug, and Cosmetic Act to extend the authority of the Secretary of Health and Human Services to issue priority review vouchers to encourage treatments for rare pediatric diseases.

Expired in House committee

Derived from the legislative history, not an official disposition.

Latest actionReferred to Health

This bill’s path

This is H.R. 7384’s recorded path, not a universal congressional workflow.

How bills become lawAll actions
  1. Introduced

  2. Passed House

  3. Passed Senate

  4. Sent to President

  5. Signed into law

  6. Expired

Sponsor
Rep. Michael T. McCaul (R-TX-10)
Cosponsors
66 cosponsors

5 original · 61 later

28 R · 38 D

  1. Rep. Michael C. Burgess (R-TX-26)· Original · Feb 15, 2024
  2. Rep. Gus M. Bilirakis (R-FL-12)· Original · Feb 15, 2024
  3. Rep. Nanette Diaz Barragán (D-CA-44)· Original · Feb 15, 2024
  4. Rep. Anna G. Eshoo (D-CA-16)· Original · Feb 15, 2024
  5. Rep. Lori Trahan (D-MA-3)· Original · Feb 15, 2024
  6. Rep. Kathy Castor (D-FL-14)· Later · Feb 26, 2024
  7. Rep. Earl L. "Buddy" Carter (R-GA-1)· Later · Feb 26, 2024
  8. Rep. Mike Kelly (R-PA-16)· Later · Feb 26, 2024
  9. Res. Comm. Jenniffer González-Colón (R-PR)· Later · Feb 28, 2024
  10. Rep. Bill Huizenga (R-MI-4)· Later · Feb 28, 2024
  11. Rep. Richard Hudson (R-NC-9)· Later · Feb 28, 2024
  12. Rep. Diana Harshbarger (R-TN-1)· Later · Feb 28, 2024
  13. Del. Eleanor Holmes Norton (D-DC)· Later · Feb 28, 2024
  14. Rep. Joe Wilson (R-SC-2)· Later · Feb 28, 2024
  15. Rep. Mike Garcia (R-CA-27)· Later · Feb 29, 2024
  16. Rep. Donald G. Davis (D-NC-1)· Later · Mar 1, 2024
  17. Rep. Troy Balderson (R-OH-12)· Later · Mar 5, 2024
  18. Rep. Deborah K. Ross (D-NC-2)· Later · Mar 5, 2024
  19. Rep. Mikie Sherrill (D-NJ-11)· Later · Mar 5, 2024
  20. Rep. Jefferson Van Drew (R-NJ-2)· Later · Mar 8, 2024
  21. Rep. Jason Crow (D-CO-6)· Later · Mar 12, 2024
  22. Rep. Kevin Hern (R-OK-1)· Later · Mar 12, 2024
  23. Rep. Kevin Kiley (R-CA-3)· Later · Mar 12, 2024
  24. Rep. Dan Crenshaw (R-TX-2)· Later · Mar 13, 2024
  25. Rep. Jeff Duncan (R-SC-3)· Later · Mar 15, 2024
  26. Rep. John Joyce (R-PA-13)· Later · Mar 19, 2024
  27. Rep. Zoe Lofgren (D-CA-18)· Later · Mar 26, 2024
  28. Rep. Josh Gottheimer (D-NJ-5)· Later · Mar 29, 2024
  29. Rep. Randy K. Weber, Sr. (R-TX-14)· Later · Apr 9, 2024
  30. Rep. Darren Soto (D-FL-9)· Later · May 8, 2024
  31. Rep. Neal P. Dunn (R-FL-2)· Later · May 14, 2024
  32. Rep. Andy Harris (R-MD-1)· Later · May 15, 2024
  33. Rep. Debbie Wasserman Schultz (D-FL-25)· Later · May 21, 2024
  34. Rep. Sharice Davids (D-KS-3)· Later · May 23, 2024
  35. Rep. Brian K. Fitzpatrick (R-PA-1)· Later · May 24, 2024
  36. Rep. William R. Keating (D-MA-9)· Later · Jun 7, 2024
  37. Rep. Wiley Nickel (D-NC-13)· Later · Jun 7, 2024
  38. Rep. Robert J. Wittman (R-VA-1)· Later · Jun 11, 2024
  39. Rep. Mike Flood (R-NE-1)· Later · Jun 12, 2024
  40. Rep. John B. Larson (D-CT-1)· Later · Jun 18, 2024
  41. Rep. Chrissy Houlahan (D-PA-6)· Later · Jun 25, 2024
  42. Rep. Michael Lawler (R-NY-17)· Later · Jun 25, 2024
  43. Rep. Kevin Mullin (D-CA-15)· Later · Jun 25, 2024
  44. Rep. Mark DeSaulnier (D-CA-10)· Later · Jul 8, 2024
  45. Rep. Suzanne Bonamici (D-OR-1)· Later · Jul 18, 2024
  46. Rep. Dean Phillips (D-MN-3)· Later · Jul 22, 2024
  47. Rep. Betty McCollum (D-MN-4)· Later · Aug 6, 2024
  48. Rep. Mike Quigley (D-IL-5)· Later · Aug 6, 2024
  49. Rep. Bradley Scott Schneider (D-IL-10)· Later · Aug 9, 2024
  50. Rep. Lloyd Smucker (R-PA-11)· Later · Aug 20, 2024
  51. Rep. Salud O. Carbajal (D-CA-24)· Later · Sep 3, 2024
  52. Rep. Jake Auchincloss (D-MA-4)· Later · Sep 11, 2024
  53. Rep. Raja Krishnamoorthi (D-IL-8)· Later · Sep 11, 2024
  54. Rep. James P. McGovern (D-MA-2)· Later · Sep 11, 2024
  55. Rep. Sheila Cherfilus-McCormick (D-FL-20)· Later · Sep 17, 2024
  56. Rep. Derek Kilmer (D-WA-6)· Later · Sep 17, 2024
  57. Rep. John H. Rutherford (R-FL-5)· Later · Sep 17, 2024
  58. Rep. Sean Casten (D-IL-6)· Later · Sep 23, 2024
  59. Rep. Donald Norcross (D-NJ-1)· Later · Sep 24, 2024
  60. Rep. Lance Gooden (R-TX-5)· Later · Sep 25, 2024
  61. Rep. Frank J. Mrvan (D-IN-1)· Later · Nov 5, 2024
  62. Rep. Chris Pappas (D-NH-1)· Later · Nov 12, 2024
  63. Rep. Chellie Pingree (D-ME-1)· Later · Nov 14, 2024
  64. Rep. Don Bacon (R-NE-2)· Later · Nov 21, 2024
  65. Rep. Abigail Davis Spanberger (D-VA-7)· Later · Dec 3, 2024
  66. Rep. Joe Neguse (D-CO-2)· Later · Jan 3, 2025
Policy area
Health
Subjects
  • Child health
  • Drug safety, medical device, and laboratory regulation
  • Prescription drugs

On this page

Timeline

i

In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.

  1. Introduced in House

    Document: Introduced in House

    Sources
  2. Latest
    ▸ 2 committee actions · Feb 15, 2024 – Feb 16, 2024
    1. Referred to committee

      Referred to the House Committee on Energy and Commerce.

      Sources
    2. Referred to Health

      Referred to the Subcommittee on Health.

      Sources
  3. Expired

    Introduced → Referred to House Health → No further action before the 118th Congress ended.

Committees

  1. HouseEnergy and CommerceReferred Feb 15, 2024
  2. HouseHealthReferred Feb 16, 2024
    1. May 16, 2024 · Markup

    2. Feb 29, 2024 · Hearing

Text & titles

i

Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.

Text versions
VersionDateLinks
Introduced in House
Titles (2)
  1. Creating Hope Reauthorization Act of 2024

    Display title, Short title · Introduced in House

  2. To amend the Federal Food, Drug, and Cosmetic Act to extend the authority of the Secretary of Health and Human Services to issue priority review vouchers to encourage treatments for rare pediatric diseases.

    Official title · Introduced in House